ETX-018810

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameETX-018810
Drug Alias NameETX-018810ETX018810ETX-810
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsCannabinoid receptor agonists
TargetsPeroxisome proliferator-activated receptor αCannabinoid receptor
Therapy Area/IndicationsDiabetic peripheral neuropathyRadiculopathyDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEliem Therapeutics (UK) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEliem Therapeutics (UK) Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyRadiculopathyDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A